ase. Nat Med 2: 864870. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein “9184477 and presenilin 1 transgenes. Nat Med 4: 97100. Borchelt DR, Lee MK, Gonzales V, Slunt HH, Ratovitski T, et al. Accumulation of proteolytic fragments of mutant presenilin 1 and accelerated amyloid deposition are co-regulated in transgenic mice. Neurobiol Aging 23: 171177. Radde R, Bolmont T, Kaeser SA, Coomaraswamy J, Lindau D, et al. Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep 7: 940946. 47. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, et al. Mutation of the beta-amyloid precursor protein in familial Alzheimer’s disease increases beta-protein production. Nature 360: 672674. 48. Haass C, Lemere CA, Capell A, Citron M, Seubert P, et al. The Swedish mutation causes early-onset Alzheimer’s disease by beta-secretase cleavage within the secretory pathway. Nat Med 1: 12911296. 49. Munter LM, Botev A, Richter L, Hildebrand PW, Althoff V, et al. Aberrant amyloid precursor protein processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif. J Biol Chem 285: 2163621643. 50. Citron M, Eckman CB, Diehl TS, Corcoran C, Ostaszewski BL, et al. Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-protein. Neurobiol Dis 5: 107116. 51. Dumanchin C, Tournier I, Martin C, Didic M, Belliard S, et al. Biological effects of four PSEN1 gene mutations causing Alzheimer disease with spastic paraparesis and cotton wool plaques. Hum Mutat 27: 1063. 52. Kumar-Singh S, Theuns J, Van Broeck B, Pirici D, Vennekens K, et al. Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40. Hum Mutat 27: 686695. 53. Steiner H, Romig H, Grim MG, Philipp U, Pesold B, et al. The biological and pathological function of the presenilin-1 Deltaexon 9 mutation is independent of its defect to undergo proteolytic processing. J Biol Chem 274: 76157618. 54. Houlden H, Baker M, McGowan E, Lewis P, Hutton M, et al. Variant Alzheimer’s disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta 
concentrations. Ann Neurol 48: 806808. 55. Pardossi-Piquard R, Petit A, Kawarai T, Sunyach C, Alves da Costa C, et al. Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP. Neuron 46: 541554. 56. Veeraraghavalu K, Choi SH, Zhang X, Sisodia SS Presenilin 1 mutants impair the self-renewal and differentiation of adult murine subventricular zoneneuronal progenitors via cell-autonomous mechanisms involving notch signaling. J Neurosci 30: 69036915. 57. Saura CA, Choi SY, Beglopoulos V, Malkani S, Zhang D, et al. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42: 2336. 58. Wolfe MS 946128-88-7 web gamma-Secretase inhibitors and modulators for Alzheimer’s disease. Journal of “2436504 neurochemistry 120 Suppl 1: 8998. 59. Schor NF What the halted phase III gamma-secretase inhibitor trial may be telling us. Annals of neurology 69: 237239. 60. Xu X Gamma-secretase catalyzes sequential cleavages of the AbetaPP transmembrane domain. Journal of Alzheimer’s di
Potassium channel potassiun-channel.com
Just another WordPress site
